IDH1 and acute myeloid leukemia: Stuani et al. reported that in a cell line model of IDH1R132H AML, proteomic, lipidomic and isotope-labeled glucose and glutamine approaches to profile the metabolic status of IDH1-mutated vs. wildtype cells, revealed that mutant IDH1 directs high lipid anabolism (231).